Your browser doesn't support javascript.
loading
Changes in the epidemiology of kidney replacement therapy across Europe in 2020 - the first year of the COVID-19 pandemic: an ERA Registry study.
Kramer, Anneke; Jager, Kitty J; Chesnaye, Nicholas C; Kerschbaum, Julia; Hommel, Kristine; Farnés, Jordi Comas; Alemán, Sara Trujillo; Santamaria, Rafael; Finne, Patrik; Hemmelder, Marc H; Åsberg, Anders; Nitsch, Dorothea; Ambühl, Patrice; Sørensen, Søren S; Sánchez-Alvarez, J Emilio; Segelmark, Mårten; Resic, Halima; Ots-Rosenberg, Mai; Radunovic, Danilo; Palsson, Runolfur; de Pablos, Carmen Santiuste; Arévalo, Olga Lucia Rodríguez; Legeai, Camille; Lausevic, Mirjana; Bakkaloglu, Sevcan A; Ortiz, Alberto; Stel, Vianda S.
Affiliation
  • Kramer A; ERA Registry, Amsterdam UMC location University of Amsterdam, Medical Informatics, Amsterdam, Netherlands.
  • Jager KJ; Amsterdam Public Health Research Institute, Quality of Care, Amsterdam, the Netherlands.
  • Chesnaye NC; ERA Registry, Amsterdam UMC location University of Amsterdam, Medical Informatics, Amsterdam, Netherlands.
  • Kerschbaum J; Amsterdam Public Health Research Institute, Quality of Care, Amsterdam, the Netherlands.
  • Hommel K; ERA Registry, Amsterdam UMC location University of Amsterdam, Medical Informatics, Amsterdam, Netherlands.
  • Farnés JC; Amsterdam Public Health Research Institute, Quality of Care, Amsterdam, the Netherlands.
  • Alemán ST; Austrian Dialysis and Transplant Registry, Department of Internal Medicine IV - Nephrology and Hypertension, Medical University Innsbruck, Innsbruck, Austria.
  • Santamaria R; Department of Nephrology, Holbaek Hospital, Holbaek, Denmark.
  • Finne P; Catalan Renal Registry, Catalan Transplant Organization, Health Department, Generalitat of Catalonia, Barcelona, Spain.
  • Hemmelder MH; Health Quality Assessment and Information System Service, Dirección General de Programas Asistenciales, Servicio Canario de la Salud, Las Palmas de Gran Canaria, Spain.
  • Åsberg A; Andalusian Autonomous Transplant Coordination Information System, Seville, Spain.
  • Nitsch D; Nephrology Service, Reina Sofia University Hospital, Cordoba, Spain.
  • Ambühl P; Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Sørensen SS; Department of Internal Medicine, Division of Nephrology, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Sánchez-Alvarez JE; CARIM school for cardiovascular diseases, University of Maastricht, Maastricht, the Netherlands.
  • Segelmark M; Department of Transplantation Medicine, Oslo University Hospital - Rikshospitalet, Oslo, Norway.
  • Resic H; UK Renal Registry, Bristol, UK.
  • Ots-Rosenberg M; Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
  • Radunovic D; Institute of Nephrology, Waid and Triemli City Hospital, Zurich, Switzerland.
  • Palsson R; Department of Nephrology P, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.
  • de Pablos CS; Department of Nephrology, Hospital Universitario de Cabuenes, Gijón, Asturias, Spain.
  • Arévalo OLR; Department of Clinical Sciences, Lund University, Lund, Sweden.
  • Legeai C; Department of Endocrinology, Nephrology and Rheumatology, Skane University Hospital, Lund, Sweden.
  • Lausevic M; Society of Nephrology And Dialysis of Bosnia and Herzegovina, Sarajevo, Bosnia and Herzegovina.
  • Bakkaloglu SA; Department of Internal Medicine, Tartu University Hospital, Estonia.
  • Ortiz A; Clinical Center of Montenegro, Clinic for Nephrology, Podgorica, Montenegro.
  • Stel VS; Division of Nephrology, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland.
Article in En | MEDLINE | ID: mdl-38889925
ABSTRACT

BACKGROUND:

In 2020, the COVID-19 pandemic caused disruptions in kidney replacement therapy (KRT) services worldwide. The aim of this study was to assess the effect of the COVID-19 pandemic in 2020 on the incidence of KRT, kidney transplantation activity, mortality and prevalence of KRT across Europe.

METHODS:

Patients receiving KRT were included from 17 countries providing data to the European Renal Association Registry. The epidemiology of KRT in 2020 was compared with average data from the period 2017-2019. Also changes occurring during the first and second wave of the pandemic were explored.

RESULTS:

The incidence of KRT was 6.2% lower in 2020 compared with 2017-2019, with the lowest point (-22.7%) during the first wave in April. The decrease varied across countries, was smaller in males (-5.2%) than in females (-8.2%), and was moderate for peritoneal dialysis (-3.7%) and haemodialysis (-5.4%), but substantial for pre-emptive kidney transplantation (-23.6%). The kidney transplantation rate decreased by 22.5%, reaching a nadir of -80.1% during the first wave, and most for living donor kidney transplants (-30.5%). While in most countries the kidney transplantation rate decreased, in the Nordic/Baltic countries and Greece there was no clear decline. In dialysis patients, mortality increased by 11.4%, and was highest in those aged 65-74 years (16.1%), in those with diabetes as primary renal disease (15.1%), and in those on haemodialysis (12.4%). In transplant recipients, the mortality was 25.8% higher, but there were no subgroups that stood out. In contrast to the rising prevalence of KRT observed over the past decades across Europe, the prevalence at the end of 2020 (N=317787) resembled that of 2019 (N=317077).

CONCLUSION:

The COVID-19 pandemic has had a substantial impact on the incidence of KRT, kidney transplant activity, mortality of KRT, and prevalence of KRT in Europe with variations across countries.
Key words

Full text: 1 Database: MEDLINE Language: En Journal: Nephrol Dial Transplant Journal subject: NEFROLOGIA / TRANSPLANTE Year: 2024 Type: Article Affiliation country: Netherlands

Full text: 1 Database: MEDLINE Language: En Journal: Nephrol Dial Transplant Journal subject: NEFROLOGIA / TRANSPLANTE Year: 2024 Type: Article Affiliation country: Netherlands